{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:26Z","timestamp":1786981226647,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10792-021-01696-2","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T16:02:56Z","timestamp":1611763376000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-793X","authenticated-orcid":false,"given":"Ahmet Yucel","family":"Ucgul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Behcet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/OPTH.S181997","volume":"14","author":"S Egrilmez","year":"2020","unstructured":"Egrilmez S, Yildirim-Theveny S (2020) Treatment-resistant bacterial keratitis: challenges and solutions. Clin Ophthalmol 14:287\u2013297","journal-title":"Clin Ophthalmol"},{"key":"1696_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2020.03.017","volume":"214","author":"AF Durrani","year":"2020","unstructured":"Durrani AF, Atta S, Bhat A et al (2020) Methicillin-resistant Staphylococcal aureus keratitis: initial treatment, risk factors, clinical features, and treatment outcomes. Am J Ophthalmol 214:119\u2013126","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"1696_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/bjophthalmol-2015-307371","volume":"100","author":"D Robaei","year":"2016","unstructured":"Robaei D, Carnt N, Watson S (2016) Established and emerging ancillary techniques in management of microbial keratitis: a review. Br J Ophthalmol 100(9):1163\u20131170","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1696_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/ICO.0000000000002186","volume":"39","author":"EG Romanowski","year":"2020","unstructured":"Romanowski EG, Romanowski JE, Shanks RMQ et al (2020) Topical vancomycin 5% is more efficacious than 2.5% and 1.25% for reducing viable methicillin-resistant staphylococcus aureus in infectious keratitis. Cornea 39(2):250\u2013253","journal-title":"Cornea"},{"key":"1696_CR5","doi-asserted-by":"crossref","unstructured":"Flynn HW, Batra NR, Schwartz SG, Grzybowski A. (2018) Antimicrobial treatment: routes\/dosages\/preparation\/adverse effects, antimicrobial resistance, and alternatives. Endophthalmitis in clinical practice, Springer, pp 123\u2013139","DOI":"10.1007\/978-3-319-66351-7_5"},{"issue":"11","key":"1696_CR6","doi-asserted-by":"publisher","first-page":"e80119","DOI":"10.1371\/journal.pone.0080119","volume":"8","author":"SJ Ong","year":"2013","unstructured":"Ong SJ, Huang YC, Tan HY et al (2013) Staphylococcus aureus keratitis: a review of hospital cases. PLoS ONE 8(11):e80119","journal-title":"PLoS ONE"},{"key":"1696_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","volume":"21","author":"Y Cong","year":"2020","unstructured":"Cong Y, Yang S, Rao X (2020) Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res 21:169\u2013176","journal-title":"J Adv Res"},{"issue":"2","key":"1696_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2165\/00044011-199612020-00003","volume":"12","author":"CY Liu","year":"1996","unstructured":"Liu CY, Lee WS, Fung CP et al (1996) Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant staphylococcus aureus bacteraemia. Clin Drug Investig 12(2):80\u201387","journal-title":"Clin Drug Investig"},{"issue":"10","key":"1696_CR9","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1128\/AAC.00341-09","volume":"53","author":"S Svetitsky","year":"2009","unstructured":"Svetitsky S, Leibovici L, Paul M (2009) Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 53(10):4069\u20134079","journal-title":"Antimicrob Agents Chemother"},{"issue":"Supplement_1","key":"1696_CR10","doi-asserted-by":"publisher","first-page":"i88","DOI":"10.1093\/jac\/dkaa086","volume":"75","author":"D Torumkuney","year":"2020","unstructured":"Torumkuney D, Tunger A, Sancak B et al (2020) Results from the Survey of antibiotic resistance (SOAR) 2015\u201317 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints. J Antimicrob Chemother 75(Supplement_1):i88\u2013i99","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"1696_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/bjs.1800831007","volume":"83","author":"RW Parks","year":"1996","unstructured":"Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T (1996) Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 83(10):1345\u20131349","journal-title":"Br J Surg"},{"issue":"10","key":"1696_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1089\/jop.2013.0120","volume":"29","author":"FZ Mengeloglu","year":"2013","unstructured":"Mengeloglu FZ, Kucukbayrak A, Bucak YY et al (2013) Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits. J Ocul Pharmacol Ther 29(10):893\u2013899","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1696_CR13","first-page":"126","volume":"35","author":"B Akova Budak","year":"2016","unstructured":"Akova Budak B, Baykara M, Kivanc SA, Yilmaz H, Cicek S (2016) Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis. Cutan Ocul Toxicol 35(2):126\u2013130","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"1696_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/jop.2014.0052","volume":"31","author":"S Goktas","year":"2015","unstructured":"Goktas S, Kurtoglu MG, Sakarya Y et al (2015) New therapy option for treatment of methicillin-resistant Staphylococcus aureus keratitis: tigecycline. J Ocul Pharmacol Ther 31(2):122\u2013127","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"1696_CR15","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1167\/iovs.09-4839","volume":"51","author":"H Sueke","year":"2010","unstructured":"Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM (2010) An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(8):4151\u20134155","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1696_CR16","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1167\/iovs.08-3201","volume":"50","author":"SB Kaye","year":"2009","unstructured":"Kaye SB, Neal T, Nicholson S et al (2009) Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea. Invest Ophthalmol Vis Sci 50(7):3176\u20133184","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 2","key":"1696_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/eye.1998.59","volume":"12","author":"MC Briggs","year":"1998","unstructured":"Briggs MC, McDonald P, Bourke R, Smith G, McGalliard JN, Wong D (1998) Intravitreal penetration of teicoplanin. Eye (Lond) 12(Pt 2):252\u2013255","journal-title":"Eye (Lond)"},{"issue":"4","key":"1696_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00417-011-1851-1","volume":"250","author":"C Irigoyen","year":"2012","unstructured":"Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H (2012) Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 250(4):499\u2013505","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1696_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00417-019-04519-4","volume":"258","author":"AA Gupta","year":"2020","unstructured":"Gupta AA, Mammo DA, Page MA (2020) Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review. Graefes Arch Clin Exp Ophthalmol 258(1):167\u2013173","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1696_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/OPTH.S135112","volume":"11","author":"WM Nada","year":"2017","unstructured":"Nada WM, Al Aswad MA, El-Haig WM (2017) Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study. Clin Ophthalmol 11:871\u2013874","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1696_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jcrs.2011.03.005","volume":"37","author":"SY Liang","year":"2011","unstructured":"Liang SY, Lee GA (2011) Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis. J Cataract Refract Surg 37(5):960\u2013962","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"1696_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.oret.2020.03.009","volume":"4","author":"HL Feng","year":"2020","unstructured":"Feng HL, Robbins CB, Fekrat S (2020) A nine-year analysis of practice patterns, microbiologic yield, and clinical outcomes in cases of presumed infectious endophthalmitis. Ophthalmol Retina 4(6):555\u2013559","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"1696_CR23","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/AAC.47.7.2334-2338.2003","volume":"47","author":"DM Citron","year":"2003","unstructured":"Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ (2003) In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 47(7):2334\u20132338","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1696_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0002-9394(86)90820-2","volume":"101","author":"AB Fleischer","year":"1986","unstructured":"Fleischer AB, Hoover DL, Khan JA, Parisi JT, Burns RP (1986) Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjunctivitis. Am J Ophthalmol 101(3):283\u2013287","journal-title":"Am J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01696-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T14:09:57Z","timestamp":1617977397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01696-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01696-2","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Animal Experiments Local Ethics Committee at the University of Abant Izzet Baysal (Bolu, Turkey) approved the study (Approval No: 2019\/41).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Plant reproducibility"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Gels and blots\/image manipulation"}}]}}